NEWSROOM

Cancer researchers at the MD Anderson Cancer Center use Redoxica's 2-Cys-Peroxiredoxin Activity Assay technology in evaluating breast cancer cell sensitivity.

Little Rock, AR - United States of America - January 2019

Cancer researchers at the MD Anderson Cancer Center use Redoxica's 2-Cys-Peroxiredoxin Activity Assay Kit (Product Code: PR-5011K) to measure the activity of 2-cys-peroxiredoxin in MCF7, MDA-MB-231 and HEK293 cells. The cells were trypsinized and washed with 1X PBS Buffer (Product Code: PH9007-500ML) and then sonicated in assay buffer. Subsequently, they determined that SIRT2 deacetylates and inhibits the peroxidase activity of peroxiredoxin-1 to sensitize breast cancer cells to oxidant stress-inducing agents.

news-img